Free tool
Medicare drug spending
Last checked: Nov 19, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
20
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 20 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | D | $387M | -9% | 5,266,914 | $73 | $0.28 |
| Oxycodone-Acetaminophen Oxycodone HCl/Acetaminophen | D | $243M | -7% | 2,149,560 | $113 | $0.33 |
| Percocet Oxycodone HCl/Acetaminophen | D | $60.4M | -7% | 1,989 | $30,345 | $33.90 |
| Acetaminophen-Codeine Acetaminophen With Codeine | D | $32.8M | +5% | 998,598 | $33 | $0.28 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | D | $23.3M | -20% | 193,088 | $121 | $0.52 |
| Prolate Oxycodone HCl/Acetaminophen | D | $7.4M | -36% | 633 | $11,694 | $26.47 |
| Tramadol HCl-Acetaminophen Tramadol HCl/Acetaminophen | D | $3.7M | -18% | 114,186 | $32 | $0.22 |
| Butalbital-Acetaminophen Butalbital/Acetaminophen | D | $2.4M | -13% | 4,206 | $566 | $1.93 |
| Endocet Oxycodone HCl/Acetaminophen | D | $1.3M | -54% | 14,998 | $84 | $0.34 |
| Fioricet Butalb/Acetaminophen/Caffeine | D | $935K | -6% | 356 | $2,626 | $7.03 |
| Nalocet Oxycodone HCl/Acetaminophen | D | $668K | -28% | 151 | $4,425 | $27.35 |
| Acetaminophen Acetaminophen | D | $126K | +157% | 305 | $413 | $0.20 |
| Acetaminophen (J0136) Acetaminophen · J0136 | B | $113K | n/a | 20,446 | $6 | $0.05 |
| Acetaminophen (J0134) Acetaminophen · J0134 | B | $105K | +19465% | 21,935 | $5 | $0.05 |
| Acetaminophen (J0137) Acetaminophen · J0137 | B | $44K | n/a | 7,725 | $6 | $0.05 |
| Esgic Butalb/Acetaminophen/Caffeine | D | $20K | -78% | 16 | $1,268 | $4.73 |
| Acetaminophen (J0131) Acetaminophen · J0131 | B | $11K | -6% | 1,241 | $9 | $0.07 |
| Acetamin-Caff-Dihydrocodeine Acetaminophen/Caff/Dihydrocod | D | $5K | -98% | 26 | $180 | $2.63 |
| Trezix Acetaminophen/Caff/Dihydrocod | D | $3K | -94% | 12 | $261 | $4.58 |
| Tencon Butalbital/Acetaminophen | D | $2K | -75% | 40 | $49 | $0.70 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.